Logo for Cartesian Therapeutics Inc

Cartesian Therapeutics Investor Relations Material

Latest events

Logo for Cartesian Therapeutics Inc

M&A Announcement

Cartesian Therapeutics
Logo for Cartesian Therapeutics

Q3 2024

7 Nov, 2024
Logo for Cartesian Therapeutics

Q2 2024

8 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Cartesian Therapeutics Inc

Access all reports
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing cell therapies for the treatment of autoimmune diseases and cancer. The company uses its proprietary RNA cell therapy platform to engineer immune cells with therapeutic potential. Cartesian’s therapies are designed to target specific disease pathways, aiming to provide more effective treatments with fewer side effects compared to traditional approaches. The company is headquartered in Gaithersburg, Maryland, and its shares are listed on the NASDAQ.